JANE STREET GROUP, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$14,832,000
+46.6%
638,216
+0.4%
0.03%
+30.8%
Q1 2018$10,120,000
-49.6%
635,573
-34.3%
0.03%
-55.2%
Q4 2017$20,090,000
+21.9%
966,739
-15.9%
0.06%
+9.4%
Q3 2017$16,482,000
-30.5%
1,150,105
-16.1%
0.05%
-35.4%
Q2 2017$23,714,000
+55.8%
1,370,772
-0.7%
0.08%
+22.4%
Q1 2017$15,223,000
+56.1%
1,380,108
+105.5%
0.07%
+55.8%
Q4 2016$9,752,000
-27.8%
671,651
+22.1%
0.04%
-33.8%
Q3 2016$13,508,000
-57.6%
550,190
-65.2%
0.06%
-58.9%
Q2 2016$31,822,000
-41.0%
1,580,018
-23.0%
0.16%
-47.9%
Q1 2016$53,960,000
+1.1%
2,051,713
+290.9%
0.30%
-8.7%
Q4 2015$53,354,000
+105.9%
524,876
+261.4%
0.33%
+103.7%
Q3 2015$25,910,000
+269.2%
145,248
+359.8%
0.16%
+254.3%
Q2 2015$7,017,000
+19.1%
31,590
+6.5%
0.05%0.0%
Q1 2015$5,891,000
+165.1%
29,657
+75.1%
0.05%
+100.0%
Q3 2014$2,222,000
+370.8%
16,940
+352.8%
0.02%
+283.3%
Q2 2014$472,000
-83.4%
3,741
-82.7%
0.01%
-81.2%
Q1 2014$2,849,00021,6090.03%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2017
NameSharesValueWeighting ↓
Chou Associates Management 1,648,992$38,323,00014.52%
Paulson & Co. 20,839,035$484,299,0009.89%
MILLER VALUE PARTNERS, LLC 4,999,064$116,178,0004.34%
GoldenTree Asset Management 1,140,205$26,498,0004.21%
Pomelo Capital LLC 1,760,000$40,902,0004.00%
Bruce & Co., Inc. 860,000$19,986,0003.98%
ValueAct Holdings 18,033,149$419,090,0003.79%
Stanley Capital Management, LLC 318,400$7,400,0003.25%
Kazazian Asset Management, LLC 134,784$3,132,0002.87%
Phoenix Investment Adviser LLC 58,400$1,357,0002.48%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders